Supply Chain Continuity & Redundancy Support

The contract seeks to establish a potential alternate manufacturing or backup supply capability for DaTscan™ to safeguard the continuity of supply and prevent disruptions in patient care. This initiative is critical to ensuring uninterrupted access to this essential diagnostic agent, particularly for veterans who rely on it for neurological assessments. The effort is being managed by the Department of Veterans Affairs through its Network Contract Office 19, with a focus on securing reliable redundancy in the supply chain to mitigate risks associated with single-source production. The solicitation is classified as a subcontract under NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing. Respondents must submit proposals by July 3, 2026, at 6:00 p.m. ET, with the opportunity to demonstrate the ability to produce, validate, and scale DaTscan™ using compliant, FDA-registered processes that align with current Good Manufacturing Practices. While no set-aside designation is specified, the requirement emphasizes operational readiness and the capacity to seamlessly transition production if the primary source becomes unavailable, ensuring patient safety and regulatory adherence remain paramount.